Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

BACKGROUND: Anti-tumour necrosis factor (anti-TNF) therapy has been associated with reports of rapid severe progression of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). However, reports also exist of favourable responses to anti-TNF therapy in patients with ILD. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon, W G, Hyrich, K L, Watson, K D, Lunt, M, Symmons, D P M
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935328/
https://www.ncbi.nlm.nih.gov/pubmed/20444754
http://dx.doi.org/10.1136/ard.2009.120626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935328/
https://www.ncbi.nlm.nih.gov/pubmed/20444754
http://dx.doi.org/10.1136/ard.2009.120626

Ejemplares similares